Key considerations for planning adaptive platform trials: part 1
Anders Perner(Copenhagen University Hospital), Benjamin Skov Kaas‐Hansen(Copenhagen University Hospital), Aldana Rosso(Rigshospitalet), Jeanett Friis Rohde(Frederiksberg Hospital), Rikke Faebo Larsen(Copenhagen University Hospital), Inger Katrine Dahl-Petersen(Copenhagen University Hospital), Morten Hylander Møller(Copenhagen University Hospital), Maj-Brit N. Kjær(Copenhagen University Hospital)
Cited by 0
Related Papers
Restriction of Intravenous Fluid in ICU Patients with Septic Shock
|New England Journal of Medicine|2022|380
Dynamic and explainable machine learning prediction of mortality in patients in the intensive care unit: a retrospective study of high-frequency data in electronic patient records
|The Lancet Digital Health|2020|339
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
|The Lancet Rheumatology|2020|153
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study
|Nature Communications|2020|107